Literature DB >> 7824320

[Epidemiological studies of the susceptibility of Pseudomonas aeruginosa to antibiotics].

F Bert1, B Bruneau, N Lambert-Zechovsky, C Branger.   

Abstract

The susceptibility to antibiotics of 1367 non-replicate strains of Pseudomonas aeruginosa isolated at Beaujon Hospital between 1990 and 1992 was investigated and compared with the serogroup O and the strain origin (ward, sample). Five betalactam resistance patterns were distinguished according to susceptibility to ticarcillin, piperacillin, ceftazidime and aztreonam,: 1 = SSSS, 2 = RRSS, 3 = RRRR, 4 = RSSR, 5 = RRSR. The other antibiotics studied were imipenem, tobramycin, amikacin, ciprofloxacin and fosfomycin. Resistance to all antibiotics, fosfomycin excepted, was higher in intensive care units than in other wards. The respective frequencies of the phenotypes were: 70.3%, 4.3%, 11.8%, 10.2% and 3.4%. The frequency of pattern 3 steadily increased between 1990 and 1992 at the expense of pattern 1, whereas patterns 2, 4 and 5 remained stable. The most common serogroups were O6 (15.8%), O11 (14.5%) and O1 (9.9%). The O11 strains were more widespread in intensive care units than in other wards and were more resistant to antibiotics. Most of the O12 strains displayed pattern 2 and were highly resistant to antibiotics.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7824320

Source DB:  PubMed          Journal:  Pathol Biol (Paris)        ISSN: 0369-8114


  3 in total

Review 1.  A reappraisal of current dosing strategies for intravenous fosfomycin in children and neonates.

Authors:  Friederike Traunmüller; Martin Popovic; Karl-Heinz Konz; Patrick Vavken; Andreas Leithner; Christian Joukhadar
Journal:  Clin Pharmacokinet       Date:  2011-08       Impact factor: 6.447

2.  Bactericidal effect of pefloxacin and fosfomycin against Pseudomonas aeruginosa in a rabbit endocarditis model with pharmacokinetics of pefloxacin in humans simulated in vivo.

Authors:  D Bugnon; G Potel; Y Q Xiong; J Caillon; D Navas; C Gras; M F Kergueris; P Le Conte; F Jehl; D Baron; H Drugeon
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-08       Impact factor: 5.103

3.  Pseudomonas aeruginosa serotypes in nosocomial pneumonia: prevalence and clinical outcomes.

Authors:  Qin Lu; Philippe Eggimann; Charles-Edouard Luyt; Michel Wolff; Michael Tamm; Bruno François; Emmanuelle Mercier; Jorge Garbino; Pierre-François Laterre; Holger Koch; Verena Gafner; Michael P Rudolf; Erkan Mus; Antonio Perez; Hedvika Lazar; Jean Chastre; Jean-Jacques Rouby
Journal:  Crit Care       Date:  2014-01-15       Impact factor: 9.097

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.